27 studies found for:    S1107
Show Display Options
Rank Status Study
1 Active, not recruiting Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot be Removed by Surgery
Conditions: Childhood Renal Cell Carcinoma;   Recurrent Renal Cell Cancer;   Stage III Renal Cell Cancer;   Stage IV Renal Cell Cancer;   Type 1 Papillary Renal Cell Carcinoma;   Type 2 Papillary Renal Cell Carcinoma
Interventions: Drug: tivantinib;   Drug: erlotinib hydrochloride;   Other: laboratory biomarker analysis
2 Completed A Study of S-297995 for the Treatment of Opioid-Induced Constipation in Subjects With Non-Malignant Chronic Pain Receiving Opioid Therapy
Condition: Opioid Induced Constipation
Interventions: Drug: Placebo once daily;   Drug: 0.1 mg of S-297995 once daily;   Drug: 0.2 mg of S-297995 once daily;   Drug: 0.4 mg of S-297995 once daily
3 Completed Clofarabine and Temsirolimus in Treating Older Patients With Relapsed or Refractory Acute Myeloid Leukemia
Condition: Leukemia
Interventions: Drug: clofarabine;   Drug: temsirolimus
4 Active, not recruiting XParTS II: Capecitabine/CDDP(XP) and S-1/CDDP(SP) as the First-line Treatment for Advanced Gastric Cancer
Condition: Gastric Cancer
Interventions: Drug: SP;   Drug: XP
5 Recruiting Study Conducted in Subjects With Rheumatoid Arthritis Who Have Moderate to Severe Disease Activity Despite Methotrexate Therapy With or Without Other Non Biologic Disease Modifying Antirheumatic Drugs (DMARDs)for at Least 12 Weeks Prior to Screening
Condition: Rheumatoid Arthritis
Interventions: Drug: Etanercept;   Drug: placebo
6 Recruiting A Phase II Study of Everolimus in Combination With Exemestane Versus Everolimus Alone Versus Capecitabine in Advance Breast Cancer.
Condition: Breast Cancer
Interventions: Drug: Capecitabine;   Drug: Exemestane;   Drug: Everolimus
7 Completed
Has Results
A Study of Exercise Endurance and Lung Hyperinflation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Aclidinium Bromide;   Drug: Placebo
8 Recruiting Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer.(MONALEESA-2)
Condition: Advanced, Metastatic Breast Cancer
Interventions: Drug: LEE011;   Drug: Letrozole;   Drug: LEE011 Placebo
9 Completed
Has Results
PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes
Condition: Stroke
Interventions: Drug: Aggrenox;   Drug: Clopidogrel placebo;   Drug: Micardis;   Drug: Aggrenox placebo;   Drug: Clopidogrel;   Drug: Micardis placebo
10 Completed A Study of Avastin (Bevacizumab) Plus Taxane-Based Therapy in Patients With Locally Recurrent or Metastatic Breast Cancer.
Condition: Breast Cancer
Interventions: Drug: bevacizumab [Avastin];   Drug: Taxane-based chemotherapy
11 Active, not recruiting Efficacy, Safety and Evolution of Cardiovascular Parameters in Renal Transplant Recipients
Condition: Renal Transplantation
Interventions: Drug: Everolimus;   Drug: Prograf or Neoral
12 Recruiting Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections
Conditions: Mycoses;   Candidiasis, Invasive;   Candidemia
Interventions: Drug: Isavuconazole;   Drug: Caspofungin;   Drug: Voriconazole
13 Recruiting Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Exenatide Once Weekly;   Drug: Placebo
14 Completed
Has Results
RELY-ABLE Long Term Multi-center Extension of Dabigatran Treatment in Patients With Atrial Fibrillation Who Completed RE-LY Trial
Condition: Atrial Fibrillation
Interventions: Drug: dabigatran dose 1;   Drug: dabigatran dose 2
15 Completed
Has Results
For the Health of Our Children--Clinic Based Treatment of Childhood Obesity
Condition: Obesity
Intervention: Behavioral: Behavioral counseling
16 Active, not recruiting Everolimus in Combination With Trastuzumab and Paclitaxel in the Treatment of HER2 Positive Locally Advanced or Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Everolimus;   Drug: Placebo
17 Completed
Has Results
Evaluation of the Long- Term Effects of Spiriva on Lung Function in COPD Patients
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: tiotropium;   Drug: placebo
18 Recruiting A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Condition: Asthma
Interventions: Drug: Mometasone Furoate/Formoterol MDI 100/5 mcg;   Drug: Mometasone Furoate/Formoterol MDI 200/5 mcg;   Drug: Mometasone Furoate MDI 100 mcg;   Drug: Mometasone Furoate MDI 200 mcg;   Drug: Albuterol 90 mcg /salbutamol 100 mcg HFA MDI;   Drug: Prednisone/prednisolone
19 No longer available An Open Label Safety Study of Tipranavir Co-administered With Low-dose Ritonavir in Patients With Advanced HIV-1 Infection and Limited Treatment Options.
Condition: HIV Infections
Intervention: Drug: Tipranavir
20 Completed Phase II Study to Evaluate the Cardiac Safety of 2 Doses of CHF5993 Both Combined With CHF1535 BID Versus CHF1535 BID in Patients With Moderate to Severe COPD
Condition: Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: CHF1535 + CHF5992 dose 1 BID;   Drug: CHF1535 + CHF5992  dose2 BID;   Drug: CHF1535 daily dose

   Previous Page Studies Shown (1-20) Next Page (21-27) Show next page of results    Last Page
Indicates status has not been verified in more than two years